Galapagos is a biotechnology company committed to improving the lives of people with severe diseases.

We are listed on Euronext Amsterdam and Brussels and on NASDAQ, with ticker symbol GLPG. We have an international investor base, with a long term commitment to the biotech industry. Whether you are a current investor in Galapagos or are evaluating Galapagos as a potential investment opportunity, we welcome you to contact us if you have any additional questions after reviewing our website.